Compare The Magnum Ice Cream Company N.V. Ordinary Shares (MICC) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Magnum Ice Cream Company N.V. Ordinary Shares vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $17.92 (market cap $10.72B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares and Dr. Reddy's Laboratories Ltd Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while The Magnum Ice Cream Company N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| MICC | RDY | |
|---|---|---|
Market Cap | $10.72B | $10.78B |
Volume | 1,309,650 | 2,724,343 |
Sector | Consumer Staples | Health |
52-Week High | $20.42 | $15.38 |
52-Week Low | $13.06 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.14B | $10.68B |
Dividend Yield | — | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About The Magnum Ice Cream Company N.V. Ordinary Shares
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
